Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps Fernando Bermejo; Alicia Algaba; Daniel Bonillo; Laura Jiménez; Antonio Guardiola-Arévalo; María Pacheco; Ángel Castaño; Iván Guerra;

Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;

Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;